Seung Suh Hong
Direktor/Vorstandsmitglied bei OCULAR THERAPEUTIX, INC.
Vermögen: 50 918 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Seung Suh Hong
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 30 | |
Novalgen Ltd.
 Novalgen Ltd. BiotechnologyHealth Technology Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation.
9
| Subsidiary | Biotechnology | 9 |
| Subsidiary | Pharmaceuticals: Major | 4 | |
Cellemedy Co., Ltd.
 Cellemedy Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Cellemedy Co., Ltd. develops next-generation cancer treatments to improve the health of people suffering from cancer. The company is based in Seongnam-si, South Korea. The South Korean company was founded in 2016. The CEO is Ha-Chul Kim.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Seung Suh Hong
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
American Academy of Ophthalmology, Inc.
 American Academy of Ophthalmology, Inc. Miscellaneous Commercial ServicesCommercial Services American Academy of Ophthalmology, Inc. is the world's largest association of eye physicians and surgeons. The non-profit company is based in San Francisco, CA, and has subsidiaries in the United States. The company advocates for patients and the public and set standards for ophthalmic education. The organization provides information about managing a practice, clinical pearls, and how to thrive in residency for young ophthalmologists. The company also offers an Outstanding Humanitarian Service Award and have committees that are essential to the establishment and implementation of the organization's mission and strategic goals. The Academy's website, EyeSmart, provides information on eye diseases, treatments, news, and tips for lifelong eye health. The company also has a faculty development program for their annual meeting and offer a program called Eyecelerator that advances eye care innovation by connecting creative entrepreneurs with mission-driven investors and access to markets. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Chairman Director of Finance/CFO President | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Human Resources Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Axtria, Inc.
 Axtria, Inc. Packaged SoftwareTechnology Services Axtria, Inc. provides customized analytics software and client consulting services. The firm?s solutions include decision science, commercial operations cloud and cloud information management. The company was founded by Jaswinder S. Chadha and Navdeep Chadha in 2010 and is headquartered in Berkeley Heights, NJ. | Packaged Software | Director/Board Member Founder Director/Board Member | |
| TEARLAB CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
IanTech, Inc.
 IanTech, Inc. Medical SpecialtiesHealth Technology IanTech, Inc. develops ophthalmic devices for cataract surgery. Its products include miLoop, miPhaco, miMissions, and miResources. The company was founded by Luke Clauson and Sean Ianchulev and is headquartered in Reno, NV. | Medical Specialties | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Corporate Officer/Principal | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Graduate Degree | |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
AcuFocus, Inc.
 AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
| CELLTRION, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| WINDTREE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| American Society of Cataract & Refractive Surgery Foundation | Director/Board Member Chairman | ||
| FREELINE THERAPEUTICS HOLDINGS PLC | Biotechnology | Founder Director of Finance/CFO | |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder Director/Board Member | |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
WaveTec Vision Systems, Inc.
 WaveTec Vision Systems, Inc. Electronic ComponentsElectronic Technology WaveTec Vision Systems, Inc. develops and provides wavefront measurement technologies. It focuses on research, development, manufacturing, and distribution of the Optiwave Refractive Analysis (ORA) system with VerifEye used during cataract surgery. The firm offers ophthalmic medical devices. The company was founded by Kenneth C. Aldrich, William B. Adams, Thomas J. Berryman, and Tony Van Heugten in 1997 and is headquartered in Aliso Viejo, CA. | Electronic Components | Director/Board Member Director/Board Member | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member Chief Tech/Sci/R&D Officer | |
| American Society of Retinal Specialists | Director/Board Member Director/Board Member | ||
| The Retina Society | Corporate Officer/Principal Director/Board Member | ||
| Macula Society | Corporate Officer/Principal Corporate Officer/Principal | ||
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| HARROW, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Surface Ophthalmics, Inc.
 Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Founder | |
| Indian Institute of Technology New Delhi | College/University | Undergraduate Degree Undergraduate Degree | |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The American Society of Cataract & Refractive Surgery | Director/Board Member President | ||
Augmenix, Inc.
 Augmenix, Inc. Medical SpecialtiesHealth Technology Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA. | Medical Specialties | Chief Executive Officer Chairman | |
Rejoni, Inc.
 Rejoni, Inc. BiotechnologyHealth Technology Rejoni, Inc. engages in the provision of biotechnology services. It focuses on developing products that improve the outcomes of minimally invasive and other gynecological surgical procedures. The company was founded in June 2020 and is headquartered in Bedford, MA. | Biotechnology | President Chief Executive Officer | |
Encore Vision, Inc.
 Encore Vision, Inc. Medical/Nursing ServicesHealth Services Encore Vision, Inc. operates as an ophthalmology clinic. It offers EV06, an ophthalmic pharmaceutical solution in a conventional eye drop bottle, which includes its proprietary active pharmaceutical ingredient (API). The company is headquartered in Spokane, WA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
marketRx LLC
 marketRx LLC Miscellaneous Commercial ServicesCommercial Services marketRx LLC offers analytics, market research and software services to life sciences companies. It delivers sales management and operations, brand marketing and product management, and market research services. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
TherOptix, Inc.
 TherOptix, Inc. Electronic ComponentsElectronic Technology TherOptix, Inc. develops and manufactures drug-eluting contact lens. The company is headquartered in San Francisco, CA. | Electronic Components | Director/Board Member Director/Board Member | |
| CELLTRION PHARM, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Iksuda Therapeutics Ltd.
 Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom. | Biotechnology | Director/Board Member | |
| SAREUM HOLDINGS PLC | Miscellaneous | Director/Board Member | |
| The Club Cricket Organisation Ltd. | Director/Board Member | ||
Avacta Life Sciences Ltd.
 Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Ossianix Uk Ltd. | Director/Board Member | ||
| University of California, Berkeley | College/University | Undergraduate Degree | |
| European Molecular Biology Organization | Corporate Officer/Principal | ||
TiE Boston
 TiE Boston Investment ManagersFinance TiE Boston is a private equity firm founded by by Desh Deshpande in 1997. The firm is headquartered in Boston, MA. | Investment Managers | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 37 |
| Vereinigtes Königreich | 11 |
| Südkorea | 3 |
| Indien | 2 |
| Deutschland | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 7 |
| Commercial Services | 3 |
| Finance | 3 |
| Electronic Technology | 3 |
Operativ
| Director/Board Member | 218 |
| Corporate Officer/Principal | 78 |
| Independent Dir/Board Member | 46 |
| Chief Executive Officer | 32 |
| Undergraduate Degree | 31 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Richard Lindstrom | 50 |
| Adrienne Graves | 38 |
| Bruce Peacock | 28 |
| Charles Warden | 24 |
| Michael Owen | 20 |
| Leslie Williams | 19 |
| Pravin Dugel | 17 |
| Jim O'Shea | 16 |
| Amarpreet S. Sawhney | 15 |
| Merilee Raines | 13 |
| Jeffrey S. Heier | 13 |
| Peter K. Kaiser | 9 |
| Jaswinder S. Chadha | 9 |
| Rabia Ozden | 9 |
| Christopher White | 9 |
- Börse
- Insiders
- Seung Suh Hong
- Unternehmensverbindungen